Impact of interleukin‐6 on drug transporters and permeability in the hCMEC/D3 blood–brain barrier model-Reference-Cited by-同舟云学术

Impact of interleukin‐6 on drug transporters and permeability in the hCMEC/D3 blood–brain barrier model

Published:2020-09-08 Issue:2 Volume:35 Page:397-409
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Simon Florian¹²³^ORCID,Guyot Laetitia²,Garcia Jessica²,Vilchez Gaelle⁴,Bardel Claire⁴,Chenel Marylore³,Tod Michel¹,Payen Léa²

Affiliation:

1. EA3738 Faculté de médecine de Lyon‐Sud Université de Lyon 1 165 chemin du Grand Revoyet, Faculté de médecine et maïeutique Oullins France69921France

2. Laboratoire de Biochimie‐Toxicologie Centre Hospitalier Lyon‐Sud Hospices civils de Lyon 165 chemin du Grand Revoyet Pierre‐Bénite France69310France

3. Institut de Recherches Internationales Servier Direction of Clinical PK and Pharmacometrics 50 rue Carnot Suresnes92150France

4. Hospices Civils de Lyon Department of Biostatistics 162 avenue Lacassagne Lyon69424France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12596

Reference47 articles.

1. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies

2. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells

3. Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: Implications for clinical disease